GC녹십자·한미약품, 파브리병 치료제 기술수출
High impactPredicted impact: High
Technology export up to $475M, about 38% of Hanmi Pharm's last year revenue (634.7B won deal).
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.